News

News

By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance 23 Sep, 2016
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. Send an Action Alert to your Members of Congress Today! Why do we need this action now? The last decade has seen an explosion in […] The post Action Alert: Oral Chemotherapy Parity appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance 21 Sep, 2016
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report here, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible. The post Report from the Biennial Ovarian Cancer Research Symposium appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund 16 Aug, 2016
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund 01 Aug, 2016
(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund 28 Jul, 2016
(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in […] 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance 26 Jul, 2016
Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you […] The post Research Study: Meditation appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund 18 Jul, 2016
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund 07 Jul, 2016
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and […] 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance 05 Jul, 2016
Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well […] The post Listen Now: Research Updates from 2016’s Top Medical Meetings appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund 23 Jun, 2016
(June 23, 2016) The Journal of Clinical Oncology recently published a study on the role of oral contraceptives (OC) on ovarian cancer prevention. The study, which analyzed data from 21 studies with 5, 584 cases of ovarian cancer, concluded that OC reduced the risk of a variety of invasive ovarian cancers. The risk of developing […] 
Show More
Share by: